Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports

Recruiting Observational Study
Prostate Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Male
Study type
Observational
Participants needed
4,600 (estimated)
Sponsor
First Affiliated Hospital of Wenzhou Medical University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This observational study will develop and validate a large language model-assisted workflow for imaging cTNM staging annotation and uncertainty recognition in prostate cancer using Chinese PSMA PET/CT report texts generated during routine clinical care. The study will use de-identified report texts and necessary baseline clinical information only. No additional imaging examination, blood test, tre…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male patients aged 18 years or older. 2. Patients with clinically diagnosed, pathologically diagnosed, or clinically suspected prostate cancer. 3. Patients who underwent PSMA PET/CT for initial staging, recurrence assessment, treatment response evaluation, metastatic assessme…
Contacts

Qi Lin

+86 15205771010

devillynch@126.com

CONTACT

Yikai Chen

+86 13857730804

chenyikai@wzhospital.cn

CONTACT